twitter

Monday 25 July 2016

Toxicology of a Peruvian botanical remedy to support healthy liver function

Volume 13, Issue 2, 1 June 2016, Pages 163-173

  (Article)

a  Alberta Innovates-Technology Futures, Vegreville, AB, Canada
b  Phytovox Inc., Edmonton, AB, 

Abstract

Background: The purpose of these studies was to determine the safety of a botanical treatment for supporting healthy liver function developed in Peru. The formulation, A4+, contains extracts of Curcuma longa L. rhizome (A4R), Cordia lutea Lam. flower (A4F) and Annona muricata L. leaf (A4L). The tests were used to support an application for a non-traditional Natural Health Product Licence from the Natural Health Product Directorate of Health Canada and future clinical trials. Methods: Besides reviewing the scientific and clinical information from Peru on the ingredients and conducting an initial Ames test for mutagenicity, we analysed A4+ for its chemical profile and tested genotoxicity (micronucleus test) and general toxicity (28-day repeated dose). Results: A4+ and extracts from the three plants provided distinctive chemical fingerprints. A4L contained acetogenins, requiring a second chromatographic method to produce a specific fingerprint. The Ames test proved positive at the highest concentration (5,000μg/mL) but A4+ showed no evidence of genotoxicity in the more specific mouse micronucleus test. The 28-day repeated dose (general toxicity) study in rats showed no toxicity at 2,000mg/kg. Conclusions: We conclude that under the conditions of these studies, A4+ shows no evidence of toxicity at the levels indicated. A no observed adverse effect level (NOAEL) of 2,000mg/kg was assigned. © 2016 by De Gruyter.

Author keywords

Annona muricata; Cordia lutea; Curcuma longa; herbal medicine; liver disease; toxicity testing
ISSN: 15533840Source Type: Journal Original language: English
DOI: 10.1515/jcim-2015-0054Document Type: Article
Publisher: Walter de Gruyter GmbH

  Green, F.H.Y.; Snyder Institute for Chronic Diseases, Faculty of Medicine, University of Calgary, 3280 Hospital Drive N.W., Canada; email:fgreen@ucalgary.ca
© Copyright 2016 Elsevier B.V., All rights reserved.